PURPOSE: Improvement in US survival rates among adolescents and young adults (AYAs, ages 15 through 39 years inclusive) diagnosed with non-Hodgkin lymphoma (NHL) has been documented over the last two decades. We examined national trends in survival disparities for AYAs with NHL by race/ethnicity and socioeconomic status (SES, county-level poverty) to further understand NHL and to begin monitoring health outcome disparities for this disease. METHODS: Surveillance Epidemiology and End Results data were used to calculate 5-year relative survival rates of AYAs diagnosed with NHL from 1992 to 2007 and followed through 2011. Absolute and relative disparities were computed using HD*Calc. Whether a significant linear trend was present was evaluated using Joinpoint. Analyses were replicated after excluding individuals with known HIV infection. RESULTS: The study sample included 9,573 total and 7,121 non-HIV cases of NHL. Five-year survival rates improved for all groups over time. Significant decreases were found in absolute disparities for race/ethnicity (non-HIV), in relative disparities for SES (total) and race/ethnicity (total and non-HIV) (all p < 0.05). Survival rates of non-Hispanic Blacks and Hispanics remained below than those of non-Hispanic Whites throughout the time period. CONCLUSION: Absolute and relative disparities in 5-year survival narrowed for AYAs with NHL over the time period. To continue to promote this trend, future research should investigate factors, particularly diagnostic delays and barriers to care, which continue to contribute to SES and racial/ethnic differences in survival. These factors may be particularly relevant to identify given the recent Affordable Care Act, which is designed to increase access to medical services, particularly for young adults.
PURPOSE: Improvement in US survival rates among adolescents and young adults (AYAs, ages 15 through 39 years inclusive) diagnosed with non-Hodgkin lymphoma (NHL) has been documented over the last two decades. We examined national trends in survival disparities for AYAs with NHL by race/ethnicity and socioeconomic status (SES, county-level poverty) to further understand NHL and to begin monitoring health outcome disparities for this disease. METHODS: Surveillance Epidemiology and End Results data were used to calculate 5-year relative survival rates of AYAs diagnosed with NHL from 1992 to 2007 and followed through 2011. Absolute and relative disparities were computed using HD*Calc. Whether a significant linear trend was present was evaluated using Joinpoint. Analyses were replicated after excluding individuals with known HIV infection. RESULTS: The study sample included 9,573 total and 7,121 non-HIV cases of NHL. Five-year survival rates improved for all groups over time. Significant decreases were found in absolute disparities for race/ethnicity (non-HIV), in relative disparities for SES (total) and race/ethnicity (total and non-HIV) (all p < 0.05). Survival rates of non-Hispanic Blacks and Hispanics remained below than those of non-Hispanic Whites throughout the time period. CONCLUSION: Absolute and relative disparities in 5-year survival narrowed for AYAs with NHL over the time period. To continue to promote this trend, future research should investigate factors, particularly diagnostic delays and barriers to care, which continue to contribute to SES and racial/ethnic differences in survival. These factors may be particularly relevant to identify given the recent Affordable Care Act, which is designed to increase access to medical services, particularly for young adults.
Authors: Nancy Breen; Susan Scott; Antoinette Percy-Laurry; Denise Lewis; Russell Glasgow Journal: Am J Public Health Date: 2014-07-17 Impact factor: 9.308
Authors: Theresa H M Keegan; Li Tao; Mindy C DeRouen; Xiao-Cheng Wu; Pinki Prasad; Charles F Lynch; Margarett Shnorhavorian; Brad J Zebrack; Roland Chu; Linda C Harlan; Ashley W Smith; Helen M Parsons Journal: J Cancer Surviv Date: 2014-01-10 Impact factor: 4.442
Authors: Deirdre P Cronin; Linda C Harlan; Limin X Clegg; Jennifer L Stevens; Gigi Yuan; Thomas A Davis Journal: Hematol Oncol Date: 2005-06 Impact factor: 5.271
Authors: Rami S Komrokji; Najla H Al Ali; M S Beg; Malek M Safa; Dana Rollison; Mohamed Kharfan-Dabaja; Celeste Bello; Jennifer Cultrera; Lubomir Sokol; Javier Pinilla-Ibarz; Eduardo M Sotomayor Journal: Clin Lymphoma Myeloma Leuk Date: 2011-04-20
Authors: Ayal A Aizer; Benjamin Falit; Mallika L Mendu; Ming-Hui Chen; Toni K Choueiri; Karen E Hoffman; Jim C Hu; Neil E Martin; Quoc-Dien Trinh; Brian M Alexander; Paul L Nguyen Journal: J Clin Oncol Date: 2014-06-02 Impact factor: 44.544
Authors: Theresa H M Keegan; Lisa M Moy; James M Foran; Ash A Alizadeh; Ellen T Chang; Sarah J Shema; Clayton W Schupp; Christina A Clarke; Sally L Glaser Journal: Leuk Lymphoma Date: 2012-09-28
Authors: Erin E Kent; Rebecca A Morris; Joan A Largent; Argyrios Ziogas; Leonard S Sender; Hoda Anton-Culver Journal: J Cancer Epidemiol Date: 2010-06-22
Authors: Rebecca D Kehm; Logan G Spector; Jenny N Poynter; David M Vock; Sean F Altekruse; Theresa L Osypuk Journal: Cancer Date: 2018-08-20 Impact factor: 6.860
Authors: Deanna Blansky; Melissa Fazzari; Ioannis Mantzaris; Thomas Rohan; H Dean Hosgood Journal: Cancer Causes Control Date: 2021-10-22 Impact factor: 2.532
Authors: S Hong; L Rybicki; D M Abounader; B J Bolwell; R Dean; A T Gerds; B K Hamilton; B T Hill; D Jagadeesh; M Kalaycio; H D Liu; B Pohlman; R Sobecks; N S Majhail Journal: Bone Marrow Transplant Date: 2016-04-25 Impact factor: 5.483
Authors: Harry Comber; Marianna De Camargo Cancela; Trutz Haase; Howard Johnson; Linda Sharp; Jonathan Pratschke Journal: PLoS One Date: 2016-12-19 Impact factor: 3.240
Authors: Olugbenga Akindele Silas; Chad J Achenbach; Lifang Hou; Robert L Murphy; Julie O Egesie; Solomon A Sagay; Oche O Agbaji; Patricia E Agaba; Jonah Musa; Agabus N Manasseh; Ezra D Jatau; Ayuba M Dauda; Maxwell O Akanbi; Barnabas M Mandong Journal: Infect Agent Cancer Date: 2017-06-05 Impact factor: 2.965
Authors: Fahad Mukhtar; Paolo Boffetta; Bashir Dabo; Jong Y Park; Chi T D Tran; Thuan V Tran; Huong Thi-Thanh Tran; Madison Whitney; Harvey A Risch; Linh C Le; Wei Zheng; Xiao-Ou Shu; Hung N Luu Journal: PLoS One Date: 2018-07-11 Impact factor: 3.240